Japan Platelet Rich Plasma (PRP) Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Pure Platelet Rich Plasma (P-PRP), Leukocyte-Rich Platelet Rich Plasma (L-PRP), and Leukocyte-Platelet-Rich Fibrin (L-PRF)), By Application (Orthopedic and Spinal Surgery, Cosmetic Surgery and Aesthetics, Neurosurgery, General Surgery, and Others), and Japan Platelet Rich Plasma (PRP) Market Insights, Industry Trend, Forecasts to 2035

Japan Platelet Rich Plasma (PRP) Market Insights Forecasts to 2035

• The Japan Platelet Rich Plasma (PRP) Market Size was estimated at USD 31.91 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 13.71% from 2025 to 2035
• The Japan Platelet Rich Plasma (PRP) Market Size is Expected to Reach USD 131.13 Million by 2035

According to a research report published by Spherical Insights and Consulting, The Japan Platelet Rich Plasma (PRP) Market Size is anticipated to reach USD 131.13 Million by 2035, growing at a CAGR of 13.71% from 2025 to 2035.  Japan's platelet rich plasma (PRP) market is driven by rising demand for regenerative medicine, increasing orthopedic and cosmetic applications, and advancements in PRP-based therapies.

Market Overview

The Japan platelet rich plasma (PRP) market refers to the industry focused on regenerative medicine treatments using PRP therapy, which involves concentrated platelets derived from a patient's own blood to accelerate healing. The rising prevalence of musculoskeletal conditions and sports-related injuries is driving growth in the Japanese platelet-rich plasma (PRP) market. The number of occurrences of joint, tendon, and ligament injuries has increased due to an older population and a growing interest in physical exercise. Orthopedic experts are increasingly using PRP therapies because of their capacity to promote healing and hasten recovery. PRP is being used in post-operative healing and chronic pain treatment regimens at hospitals and rehabilitation facilities. As patients look for alternatives to invasive surgical treatments, demand is rising.

Report Coverage

This research report categorizes the market for the Japan platelet rich plasma (PRP) market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan platelet rich plasma (PRP) market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan platelet rich plasma (PRP) market.

Driving Factors

The PRP market in Japan is growing due to several factors. The need for efficient regeneration therapies has increased due to the growing prevalence of orthopedic conditions and sports-related injuries. PRP therapy has grown in popularity as a treatment for musculoskeletal disorders because of its ability to hasten healing. The usage of PRP in aesthetic applications, like skin rejuvenation and hair restoration, has increased due to the rising popularity of cosmetic operations. The growing number of evidence-based studies showing PRP's effectiveness in wound healing, along with its growing medical applications, promotes the market's expansion. Japan's elderly population, which frequently suffers from degenerative diseases, is looking more and more for non-surgical remedies like PRP. PRP technology adoption has also been aided by government funding for clinical research projects and regenerative medicine.

Restraining Factors

The lack of established treatment protocols is one of the main issues facing the platelet rich plasma (PRP) market in Japan. Clinical results are uneven due to differences in platelet concentrations, application strategies, and PRP preparation processes. It prevents further adoption across medical institutions and undermines the trust of healthcare practitioners.

Market Segmentation

The Japan platelet rich plasma (PRP) market share is classified into product type and application.

• The leukocyte-rich platelet rich plasma (L-PRP) segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan platelet rich plasma (PRP) market is segmented by product type into pure platelet rich plasma (P-PRP), leukocyte-rich platelet rich plasma (l-PRP), and leukocyte-platelet-rich fibrin (L-PRF). Among these, the leukocyte-rich platelet rich plasma (L-PRP) segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Leukocyte-platelet-rich fibrin (L-PRF) is finding new uses in wound care and dentistry, whereas leukocyte-rich platelet rich plasma (L-PRP) is becoming more and more popular in musculoskeletal applications because of its potent healing response.

• The cosmetic surgery and aesthetics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan platelet rich plasma (PRP) market is segmented by application into orthopedic and spinal surgery, cosmetic surgery and aesthetics, neurosurgery, general surgery, and others. Among these, the cosmetic surgery and aesthetics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Aesthetics and cosmetic surgery come next, as customer demand for hair restoration and skin rejuvenation products continues to rise. To promote tissue regeneration and post-operative recovery, PRP is being progressively incorporated into the neurosurgery and general surgery subspecialties.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan platelet rich plasma (PRP) market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Rohto Pharmaceutical Co., Ltd.
• Terumo Corporation
• Fujirebio Diagnostics Japan, Inc.
• Pervice Korea Co., Ltd.
• Asahi Kasei Medical Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan platelet rich plasma (PRP) market based on the below-mentioned segments:

Japan Platelet Rich Plasma (PRP) Market, By Type

• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Platelet-Rich Fibrin (L-PRF)

Japan Platelet Rich Plasma (PRP) Market, By Application  

• Orthopedic and Spinal Surgery
• Cosmetic Surgery and Aesthetics
• Neurosurgery
• General Surgery
• Others